[ACRX] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
02-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -4.12%
YoY- -9.53%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 265 343 3,109 3,025 181 95 940 -19.01%
PBT -13,674 -11,592 -15,551 -10,979 -10,026 -9,631 -12,762 1.15%
Tax 627 136 -2,704 2 806 -618 -1,285 -
NP -13,674 -11,592 -15,551 -10,981 -10,026 -9,631 -12,762 1.15%
Tax Rate - - - - - - - -
Total Cost 13,939 11,935 18,660 14,006 10,207 9,726 13,702 0.28%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin -5,160.00 -3,379.59 -500.19 -363.01 -5,539.23 -10,137.89 -1,357.66 24.91%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -3.47 -4.55 -6.86 -4.85 -4.57 -4.46 -6.87 -10.75%
EPS Diluted -3.47 -4.55 -6.86 -4.85 -4.51 -4.46 -6.87 -10.75%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.